- Home
- ABCB vs CRNX Comparison
ABCB vs CRNX Comparison
Compare ABCB & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABCB | CRNX |
|---|---|---|
| Founded | 1971 | 2008 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ABCB | CRNX |
|---|---|---|
| Price | $83.88 | $44.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $85.71 | $75.78 |
| AVG Volume (30 Days) | 541.7K | ★ 1.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.97 | $499.13 |
| Revenue Next Year | $6.12 | $893.14 |
| P/E Ratio | $13.98 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $48.27 | $24.10 |
| 52 Week High | $87.98 | $57.99 |
Technical Indicators
Market Signals| Indicator | ABCB | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 59.50 | 36.99 |
| Support Level | $82.09 | $41.97 |
| Resistance Level | $87.98 | $48.58 |
| Average True Range (ATR) | 2.82 | 2.70 |
| MACD | -0.05 | -0.80 |
| Stochastic Oscillator | 72.18 | 17.71 |
Price Performance
Historical ComparisonAbout ABCB Ameris Bancorp
Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into four segments: the Banking Division, the Retail Mortgage Division, the Warehouse Lending Division and the Premium Finance Division. The company generates majority of its revenue from the banking division. Ameris intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.